CAI compared with HUT: revenue, margins and what each company keeps, and the suppliers and customers both name

CAICaris Life Sciences, Inc.

Mkt capRevenueRevenue

HUTHut 8 Corp.

Mkt capRevenueRevenue

Compare

CAICaris Life Sciences, Inc.

HUTHut 8 Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CAI1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±19.9%▲+21.58%×1.09

HUT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▼−9.74%×0.62

May 6 '26±8.4%▲+35.31%×4.20

= impliedCAI realized, solidHUT realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.1%

▼−6.57%

×0.59

Q3 FY25±12.9%▼−12.53%×0.97

CAICaris Life Sciences, Inc.

32.08▼−6.56%· post 32.00

Mkt cap$9.7BRevenue$264MQ2 FY26Revenue—

HUTHut 8 Corp.

55.00▼−7.41%· post 55.40

ClosedNov 2 '26

Mkt cap$7.3BRevenue$75MQ2 FY26Revenue$235MFY25

Compare

ClosedNov 2 '26

CAICaris Life Sciences, Inc.

HUTHut 8 Corp.

32.08▼−6.56%post 32.00

Price

55.00▼−7.41%post 55.40

$9.7B

Mkt cap

$7.3B

Q2 FY26$264M

Revenue

$75MQ2 FY26

—

Revenue

$235MFY25

CAI32.08▼−6.56%vsHUT55.00▼−7.41%ClosedNov 2 '26